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Abstract
Background: Chronic inflammation, possibly exacerbated by cigarette smoking, is considered to be the primary cause of  
pulmonary damage in patients with tuberculosis (TB). However, the mechanisms which underpin these harmful inflammatory 
responses, have not been well documented.
Objectives: The current study was undertaken to determine possible associations between systemic biomarkers of  inflam-
mation (acute phase reactants, stress hormones, leukocyte vitamin C) and smoking status in patients (n=71, 20 smokers) with 
newly-diagnosed pulmonary TB presenting at a tertiary hospital, Johannesburg, South Africa.
Methods: Plasma concentrations of  C-reactive protein (CRP), ferritin, cortisol, epinephrine, norepinephrine, dopamine and leu-
kocyte vitamin C were measured using a combination of  immunonephelometric, radioimmunoassay, immunochromatographic 
and spectrophotometric procedures. Demographic, clinical and laboratory data was captured and analysed by parametric and 
non-parametric analyses where appropriate.
Results: Smokers were predominantly males (P<0.0001), of  older age (P<0.0003) with a significantly lower body mass index 
(P<0.03). Plasma levels of  CRP, ferritin and dopamine were higher in the group of  smokers in the setting of  lower levels of  
epinephrine, and leukocyte vitamin C, with CRP and vitamin C attaining statistical significance (P<0.04 and P<0.02 respective-
ly). Those of  cortisol and norepinephrine were comparable to those of  non-smokers, as were radiographic changes and clinical 
indices of  disease activity. 
Conclusion: Cigarette smoking is associated with an exaggerated systemic inflammatory response in pulmonary TB in the set-
ting of  decreased concentrations of  leukocyte vitamin C. Although no significant associations with radiographic changes and 
most clinical indices of  disease activity were evident on presentation, these pro-inflammatory interactions may have prognostic 
significance.
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Cigarette smoking is not only a risk factor for the devel-
opment of  pulmonary tuberculosis (TB)1,2, but has also 
been reported to delay sputum conversion prolonging 
infectivity, to counteract the efficacy of  anti-microbial 
chemotherapy, and increase the risk of  recurrence fol-
lowing successful therapy2,3. Although the harmful effects 
of  smoking on predisposition for development of  TB 
are primarily attributed to interference with pulmonary 
host defences, pathogen-targeted mechanisms may also 
contribute2. These include smoke-activated induction of  
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biofilm formation by respiratory pathogens2,4, and pro-
motion of  gene modifications in microbial nucleic which 
may lead to antibiotic resistance5. Notwithstanding inter-
ference with pulmonary host defences, cigarette smoking 
also causes a chronic, low-grade systemic inflammatory 
response, resulting in the sustained influx of  neutrophils 
and monocytes into the lungs2, potentially intensifying 
harmful inflammatory responses and pulmonary dys-
function6.
 
Cigarette smoking and TB per se are also associated with 
altered vitamin C status due to both decreased intake and 
increased utilisation of  the vitamin7-9, presenting a po-
tential risk for increased susceptibility to TB, as well as 
disease severity. This contention is supported by several 
recent studies describing the selective anti-mycobacterial 
actions of  vitamin C, either bactericidal or bacteriostat-
ic, depending on the concentration of  the vitamin and 
availability of  iron10-12. In addition, vitamin C which is 
stored in the adrenal gland, is also required for synthe-
sis of  catecholamines13, a component of  the endogenous 
anti-inflammatory stress hormone response, which may 
ameliorate pulmonary damage and dysfunction in TB14-
16. However, the possible relationships between cigarette 
smoking, vitamin C status, and the acute phase and stress 
hormone responses in patients with pulmonary TB have 
not been well characterised.
 
This issue has been addressed in the current study in 
which a range of  circulating markers of  inflammatory ac-
tivity (acute phase reactants, stress hormones) and oxida-
tive stress (vitamin C) have been measured and compared 
with clinical and radiographic indices of  disease activity 
in newly-diagnosed, hospitalised patients with pulmonary 
TB in relation to smoking history. This is a component of  
a larger study focused on the acute and stress hormone 
responses in patients with pulmonary TB17.
 
Patients and methods
The study was approved by the Committee for Research 
on Human Subjects of  the University of  the Witwa-
tersrand (Protocol no.: MO1-11-14). Prior written in-
formed consent was obtained from all patients.
 
Patients
Seventy one newly-diagnosed, treatment-naïve patients 
with pulmonary TB admitted to Helen Joseph Hospital, 
Johannesburg were recruited in the study. All patients 
were ≥18 years of  age and TB was confirmed clinical-
ly, radiologically and microbiologically. Exclusion cri-
teria included previous TB infection and/or treatment, 
co-morbid illness (diabetes mellitus, cardiomyopathy, re-
nal failure, malignancy), those with concomitant immu-
no-suppression due to causes other than HIV infection, 
and those with AIDS-defining illnesses other than TB, as 
well as patients on highly- active anti-retroviral therapy. 
All of  the patients presented with new-onset respiratory 
symptoms to an emergency department where they were 
considered by the emergency clinician to require hos-
pitalisation for further investigation and management. 
There was no previous history of  TB or anti-mycobacte-
rial drug resistance. With respect to estimation of  length 
of  illness prior to hospitalisation, the mean durations of  
the longest symptom for the groups of  non-smokers and 
smokers were 6.8 and 8.6 weeks respectively (not signifi-
cantly different). Twenty five patients (11 females and  14 
males, 2 and 5 of  whom were smokers respectively) were 
HIV-seropositive, while the HIV-status of  the remain-
der  was unknown. To minimise the influence of  diurnal 
variation, blood specimens were taken between 0800 and 
0900 hours following an 8 hour overnight fast, processed 
promptly as required for the various specialised investiga-
tions described below and stored at -70oC until assayed. 
Following venopuncture, patients diagnosed with pulmo-
nary TB were treated with standard antibiotics.
 
Demographic and clinical data
Demographic data included age, gender, ethnicity, and 
smoking history, while clinical examination recorded 
blood pressure, pulse rate, body temperature, body height 
and weight, and body mass index (BMI, kg/m2). Weight 
loss was recorded on a “self-reporting” basis as being 
mild, moderate or severe. Patients were categorised as 
smokers on the basis of  a history of  active smoking with-
in the preceding 3 months.
 
Chest radiography
Abnormalities on chest radiographs were recorded and 
included cavitation, nodules/nodular infiltration, nodes/
hilar fullness, effusions, consolidation, and volume loss.
 
Laboratory investigations
Plasma levels of  C-reactive protein (CRP) and ferritin 
were measured using an immunonephelometric (Behring 
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Diagnostics, Marburg, Germany) and a sandwich ELI-
SA procedure (Technicon Immuno-1 System, Miles Inc., 
Diagnostic Division, Tarrytown, NY, USA) respectively, 
with the respective results recorded as micrograms (µg) 
per millilitre (mL) and nanograms (ng)/mL. The nor-
mal ranges for these acute phase reactants are <5 µg/
mL for CRP, and, in the case of  ferritin, 10-150 ng/mL 
and 12-300 ng/mL for females and males respectively. 
Concentrations of  plasma cortisol were measured by ra-
dioimmunoassay, while those of  the catecholamines(epi-
nephrine, norepinephrine, dopamine) were determined 
by a high-performance liquid chromatographic procedure 
(Bio-Rad Laboratories Diagnostic Group, CA, USA) with 
results for cortisol expressed as nanomoles (nmol)/L, 
and those of  the other 3 analytes  as picomoles (pmol)/L. 
The normal ranges for each of  these are 119-618 nmo-
l/L (cortisol), 0-366 pmol/L, (epinephrine), 560-2636 
pmol/L (norepinephrine), and 0-890 pmol/L (dopa-
mine). Following extraction, leukocyte vitamin C concen-
trations were measured using a 2,4-dinitrophenylhydra-
zine-based spectrophotometric procedure, with results 
expressed as  µg/108 cells. The mean value for leukocyte 
vitamin C for healthy control subjects for our study pop-
ulation is 26±11.2 and 30.7±11.9 µg/108 cells for females 
and males respectively18.
 
Additional investigations included measurement of  cir-
culating total leukocyte count, platelets, haemoglobin and 
mean corpuscular volume, as well as urea and creatinine 




Demographic, clinical and laboratory data were analysed 
using SPSS 7.5 and/or Graphpad Instat software. For 
evaluation of  continuous variables, normality tests were 
performed to determine normality of  distribution of  data 
with analysis thereafter using the unpaired (2-tailed) stu-
dent’s t test or the Mann-Whitney u-test for normally and 
non-normally distributed data respectively. The results are 
presented as the mean values for each parameter ± the 
standard deviation (SD) and/or 95% confidence intervals 
(CIs), together with relative risk values where appropriate. 
Log transformation of  the ferritin and leukocyte vitamin 
C data was also undertaken, but had no influence on the 
statistical analyses. For analysis of  categorical variables, 
the Fisher’s exact test (2-tailed) was performed.
 
Results
Demographic and clinical data of  patients catego-
rized according to smoking status
These are shown in Tables 1 and 2. The patient cohort 
consisted of  51 non-smokers and 20 smokers based on 
smoking history, with the smokers being predominantly 
of  male gender (P<0.0001), as described previously for 
this study group7,19, as well as being significantly older 
than the non-smokers (P<0.0003).
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Body mass index also differed between the 2 groups, be-
ing significantly lower in the group of  smokers (P<0.03), 
while self-reporting of  weight loss revealed a tenden-
cy, albeit not achieving statistical significance, towards a 
greater degree of  weight loss in the group of  smokers 
(P=0.052).
Radiographic data
Radiographic data is shown in Table 2. No differences 
between the groups of  smokers and non-smokers were 
evident.
 
Table 1: Demographic and clinical profiles of the cohort of patients with pulmonary 
tuberculosis classified according to smoking status 
   
    Non-smokers (n=51)   Smokers (n=20) P value 
Gender   31 Female 20 Male   2 Female 18 Male 0.0001 
Ethnicity   49 Black 2 Mixed Race   14 Black 6 Mixed Race 0.24 
                
    mean ±SD 95%CI   mean ±SD 95%CI   
Age (years)   32.8 8.0  30.565 – 35.82 
  41.5 10.1 36.703- 46.197 0.0003 
Body mass index 
(kg/m2) 
  18.86 4.1 17.701 – 20.016   16.87 2.5 15.696- 8.036  0.03 
Blood pressure systolic 
(mmHg) 
  103 10 100.52 – 106.15   102.6 10.4 97.752- 107.45 0.21 
Blood pressure 
diastolic (mmHg) 
  65.3 9.5 62.576 – 67.934   66.4 9.5 61.951- 70.849 0.74 
Pulse (beats/min)   101.6 16.7 96.877 – 106.30   102.6 10.4 97.752- 107.45 0.80 
Body temperature (°C)   38.68 0.73 38.386 – 38.864   38.63 0.51 38.474- 38.896 0.75 
                    
    n %   n       %   
Lymphadenopathy   25 49   10       50 1.00 
Chest dullness   36 71   17       85 0.235 
Crackles   50 98   20      100 1.00 
Bronchial breathing   10 20   4       20 1.00 
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Laboratory investigations
The results of  the various laboratory measurements are 
shown in Table 3. Concentrations of  circulating CRP and 
ferritin were higher in the group of  smokers, achieving 
statistical significance in the case of  CRP (P<0.04). Mean 
plasma concentrations of  cortisol were comparable and 
within the normal range for both groups, while epineph-
rine and norepinephrine levels were close to the upper 
limit of  normal or slightly above, with epinephrine being 
lower and dopamine higher in the group of  smokers,  al-
though not significantly so. Leukocyte vitamin C was sig-
nificantly lower in the group of  smokers (P<0.02), while 
the value for non-smokers was within the normal range. 
With respect to haematological and blood chemistry in-
dices, no statistically significant differences were evident 
between the 2 groups (data for the other parameters is 
not shown).
Table 2: Chest X-ray findings in non-smokers (n=51) and smokers (n=20)  
with pulmonary tuberculosis 
  
  Non-smokers (n) 
Smoker
s (n) RR 95% CI    P value 
  
Nodular infiltrate / 
nodules 36 15 0.94 0.6910    1.282 
  
Nodes /hilar 
fullness 35 14 0.98 0.7194    1.341 
  
Consolidation 32 11 1.10 0.8048    1.494 
  
Cavitation 29 13 0.91 0.6821    1.214 
  
Effusions 8 5 0.83 0.5261    1.310 
  
Volume loss 7 3 0.97 0.6283    1.499 
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Discussion 
In agreement with previous studies, the findings of  the 
current study have documented that patients with pulmo-
nary TB have relatively high levels of  the anti-inflamma-
tory stress hormones epinephrine and norepinephrine in 
the setting of  an intense inflammatory response reflected 
by high concentrations of  the acute phase reactants, CRP 
and ferritin7,14-16. When the patients were categorised ac-
cording to smoking status, differences emerged with re-
spect to the magnitude of  the acute phase response and 
its relationship with stress hormones, as well as with leu-
kocyte vitamin C. Cigarette smoking was found to be as-
sociated with higher concentrations of  circulating CRP 
and ferritin in the setting of  decreased concentrations of  
leukocyte vitamin C, and a decrease, albeit not attaining 
statistical significance, in the concentration of  the anti-in-
flammatory stress hormone, epinephrine, but not corti-
sol. The observed increase in CRP levels, in the group of  
smokers with TB was not detected in a previous study7, 
possibly due to differences in disease severity between the 
different patient cohorts. In this context, it is notewor-
thy that the magnitude of  the CRP response has recently 
been reported to reflect the mycobacterial load in patients 
with TB20.
 
It is noteworthy that the group of  smokers, which con-
sisted predominantly of  males as previously reported for 
this study population7, was significantly older with lower 
BMIs than the group of  non-smokers. These findings of  
the current study are consistent with a relationship be-
tween older age, male gender, smoking, and under-nu-
trition/hypovitaminosis C. The apparent exacerbation of  
the inflammatory response in smokers observed in the 
current study was not, however, associated with signifi-
cant differences in radiographic and other clinical indices 
of  disease activity. The failure to detect possible differ-
ences may be due to the relatively small numbers of  sub-
jects in each group, as well as to overall disease severity. 
Nevertheless, alterations in the concentrations of  the var-
ious measured systemic markers of  inflammation provide 
plausible support for a potentially harmful pro-inflamma-
tory interaction between pulmonary TB and smoking.
 
Vitamin C has been reported to possess bactericidal ac-
tivity against both M. bovis11 and M. tuberculosis12. In the 
latter study, a sterilizing action on M. tuberculosis was ob-
served at a vitamin C concentration of  4 millimolar (mM) 
which was dependent on the presence of  ferrous iron, 
leading to the generation of  anti-microbial hydroxyl rad-
ical. Importantly, intracellular concentrations of  vitamin 
Table 3: Acute phase reactants, leukocyte vitamin C and stress hormones in 
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C in activated monocytes and macrophages have been 
reported to be ≥ 14 mM21.The emerging role of  vitamin 
C in host defence against M. tuberculosis, mediated via its 
pro-oxidative interactions with ferrous iron10-12, may im-
plicate the involvement of  ferritin as an intracellular iron 
donor. Although generally believed to reinforce anti-ox-
idative host defences via sequestration of  iron, delivery 
of  iron to M. tuberculosis-infected macrophages represents 
an alternative, albeit pro-oxidative, protective activity 
of  ferritin22. In this context, it is noteworthy that oth-
er acute phase reactants have been reported to possess 
seemingly counteracting pro- and anti-inflammatory ac-
tivities, which are likely to be operative at different stages 
of  inflammatory responses. For example, CRP possesses 
both opsonic and complement-activating properties23,24, 
while this acute phase reactant and peptides derived from 
it have been reported to suppress neutrophil and T lym-
phocyte activation respectively25,26.
 
The association of  cigarette smoking, oxidative stress and 
depletion of  vitamin C is well recognised, with leuko-
cyte vitamin C considered to be representative of  tissue 
concentrations of  the vitamin8,9. In addition, vitamin C, 
which is stored in the adrenal gland, is not only required 
for synthesis of  catecholamines, but is also secreted in 
response to adrenocorticotrophic hormone, presumably 
as an endogenous anti-oxidative, anti-inflammatory de-
fence mechanism13. The findings of  the current study 
suggest that TB and smoking have an interactive effect 
on depletion of  tissue stores of  vitamin C. This, in turn, 
may lead to decreased efficacy of  the anti-inflammatory 
stress hormone response, specifically production of  epi-
nephrine, and an accompanying predisposition to inflam-
mation-mediated pulmonary damage. This contention is 
supported by the finding of  higher levels of  dopamine, a 
precursor of  epinephrine, in the group of  smokers.
 
Notwithstanding relatively small numbers of  patients as 
mentioned above, potential limitations of  our study in-
clude the absence of  detectable differences in the extent 
of  lung cavitation between smokers and non-smokers, 
as well as follow-up studies during treatment to monitor 
the time-course of  culture conversion between the two 
groups. In the case of  the former, however, differenc-
es in cavitation, which is largely immune-mediated, may 
be difficult to detect due to smoking-related pulmonary 
immune dysfunction; irrespective of  this caveat, a pre-
vious study involving 13,088 cases of  pulmonary TB 
has, however, documented more severe cavitary disease 
in smokers6. With respect to culture conversion, delayed 
sputum conversion in smokers has also been reported in 
several studies27-29. Follow-up studies may also identify 
the relative contributions of  infection and smoking to 
the observed alterations in vitamin C status. Additional 
limitations include the lack of  a healthy control group, 
although we believe that this limitation is largely negated 
by the inclusion of  well-established normal ranges for the 
various investigations.  Moreover, the primary objective 
of  this study was to assess the effects of  smoking on in-




The findings of  the current study are consistent with po-
tentially harmful, pro-inflammatory and pro-infective in-
teractions of  smoking and pulmonary TB associated with 
depletion of  leukocyte vitamin C. Although no differ-
ences in radiographic indices of  disease activity between 
smokers and non-smokers were evident on presentation, 
it is conceivable that the interactive pro-inflammatory ef-
fect of  smoking, which persists beyond completion of  
chemotherapy, albeit at a lower level7,8, may impact neg-
atively on the longer-term pulmonary30 and cardiovascu-
lar31 sequelae of  TB.
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